<DOC>
	<DOC>NCT00209937</DOC>
	<brief_summary>To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia</brief_summary>
	<brief_title>A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia</brief_title>
	<detailed_description>To compare the hypnotic efficacy and safety of different dose levels of gaboxadol with placebo in non-elderly patients with primary insomnia over two weeks of treatment</detailed_description>
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Gaboxadol</mesh_term>
	<criteria>diagnosis of Primary insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Primary insomnia</keyword>
</DOC>